Is a complete EVH research report available?

No complete published report is available for Evolent Health, Inc. (EVH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Evolent Health, Inc. (EVH)

NYSE: EVH · USD

$4.32

-0.10 (-2.3%)· Recorded snapshot

Market cap	488.4M
Revenue (ttm)	2.1B
Net income (ttm)	-511.1M
EPS (ttm)	-$4.54
Shares out	113.1M
P/E (forward)	12.2x
Volume	1,230,813
Beta	1.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.1B
Net income (ttm): -511.1M
EPS (ttm): -$4.54
P/E (forward): 12.2x
Market cap: 488.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Metric	Value
Amount currency	USD
CIK code	0001628908
Company name	Evolent Health, Inc.
Country	United States
Country code	US
CUSIP number	30050B101
Earnings date	2026-11-05
Earnings time	bmo
Employees	4,200
Employees change	-300
Employees growth	-6.67%
Enterprise value	$1.3B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2011
In index	RUSSELL2000
Industry	Health Information Services
IPO date	2015-06-05
Is primary listing	Yes
Is SPAC	No
ISIN number	US30050B1017
Last 10-K release date	2026-02-25
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$488.4M
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$4.32
Price currency	USD
Sector	Healthcare
SIC code	8741
Stock price date	2026-10-28
Symbol	EVH
U.S. state	Virginia
Website	https://www.evolent.com

Metric

Value

Amount currency

USD

CIK code

0001628908

Company name

Evolent Health, Inc.

Country

United States

Country code

CUSIP number

30050B101

Earnings date

2026-11-05

Earnings time

bmo

Employees

4,200

Employees change

-300

Employees growth

-6.67%

Enterprise value

$1.3B

Exchange

NYSE

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2011

In index

RUSSELL2000

Industry

Health Information Services

IPO date

2015-06-05

Is primary listing

Yes

Is SPAC

ISIN number

US30050B1017

Last 10-K release date

2026-02-25

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$488.4M

Market cap category

Small-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$4.32

Price currency

USD

Sector

Healthcare

SIC code

8741

Stock price date

2026-10-28

Symbol

EVH

U.S. state

Virginia

Website

https://www.evolent.com

Metric	Value
Adjusted P/E ratio	33.23x
Earnings yield	-105.14%
EV/EBITDA	22.04x
EV/FCF	58.64x
EV/Sales	0.64x
FCF / EV yield	1.71%
FCF yield	4.68%
Forward EV/Sales	0.43x
Forward P/E	12.22x
Forward P/S	0.16x
Industry forward P/E	34.62x
P/(OCF - SBC) ratio	43.09x
P/B ratio	1.3x
P/FCF ratio	21.39x
P/OCF ratio	9.03x
P/S ratio	0.23x
Price/EBITDA ratio	8.04x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Adjusted P/E ratio

33.23x

Earnings yield

-105.14%

EV/EBITDA

22.04x

EV/FCF

58.64x

EV/Sales

0.64x

FCF / EV yield

1.71%

FCF yield

4.68%

Forward EV/Sales

0.43x

Forward P/E

12.22x

Forward P/S

0.16x

Industry forward P/E

34.62x

P/(OCF - SBC) ratio

43.09x

P/B ratio

1.3x

P/FCF ratio

21.39x

P/OCF ratio

9.03x

P/S ratio

0.23x

Price/EBITDA ratio

8.04x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-1.33%
EBITDA margin	2.91%
FCF margin	1.09%
Gross margin	17.25%
Operating margin	-1.33%
Pretax margin	-23.95%
Profit margin	-24.08%
Profit per employee	$-121,680
Revenue per employee	$499,290
ROA	-0.78%
ROA (5Y)	-0.14%
ROCE	-1.88%
ROE	-66.97%
ROE (5Y)	-17.87%
ROIC	-2.25%
ROIC (5Y)	-0.52%
SBC / revenue	2.05%
Tax / revenue	0.14%

Metric

Value

EBIT margin

-1.33%

EBITDA margin

2.91%

FCF margin

1.09%

Gross margin

17.25%

Operating margin

-1.33%

Pretax margin

-23.95%

Profit margin

-24.08%

Profit per employee

$-121,680

Revenue per employee

$499,290

ROA

-0.78%

ROA (5Y)

-0.14%

ROCE

-1.88%

ROE

-66.97%

ROE (5Y)

-17.87%

ROIC

-2.25%

ROIC (5Y)

-0.52%

SBC / revenue

2.05%

Tax / revenue

0.14%

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	0.66%
Gross profit growth (Q)	-19.47%
Gross profit growth 3Y	-3.58%
Gross profit growth 5Y	8.85%
Net income growth quarters	2
Net income growth years	0
OCF growth 3Y	29.68%
Revenue growth	-4.5%
Revenue growth (Q)	46.86%
Revenue growth (QoQ)	31.49%
Revenue growth 10Y	26.98%
Revenue growth 3Y	8.72%
Revenue growth 5Y	17.83%
Revenue growth quarters	2
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

0.66%

Gross profit growth (Q)

-19.47%

Gross profit growth 3Y

-3.58%

Gross profit growth 5Y

8.85%

Net income growth quarters

Net income growth years

OCF growth 3Y

29.68%

Revenue growth

-4.5%

Revenue growth (Q)

46.86%

Revenue growth (QoQ)

31.49%

Revenue growth 10Y

26.98%

Revenue growth 3Y

8.72%

Revenue growth 5Y

17.83%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-31.4M
Depreciation and amortization	$88.9M
EBIT	$-27.8M
EBITDA	$61M
EPS	$-4.54
FCF per share	$0.20
Financing cash flow	$-149.8M
Free cash flow	$22.9M
Free cash flow minus SBC	$-20M
Gross profit	$361.6M
Income taxes	$2.9M
Investing cash flow	$60.3M
Net borrowing	$-103.4M
Net cash flow	$-36.5M
Net income	$-511.1M
Operating cash flow minus SBC	$11.4M
Operating income	$-27.8M
Revenue	$2.1B
Stock-based compensation	$42.9M

Metric

Value

Capital expenditures

$-31.4M

Depreciation and amortization

$88.9M

EBIT

$-27.8M

EBITDA

$61M

EPS

$-4.54

FCF per share

$0.20

Financing cash flow

$-149.8M

Free cash flow

$22.9M

Free cash flow minus SBC

$-20M

Gross profit

$361.6M

Income taxes

$2.9M

Investing cash flow

$60.3M

Net borrowing

$-103.4M

Net cash flow

$-36.5M

Net income

$-511.1M

Operating cash flow minus SBC

$11.4M

Operating income

$-27.8M

Revenue

$2.1B

Stock-based compensation

$42.9M

Metric	Value
Altman Z-Score	0.36
Book value per share	$3.40
Debt / EBITDA	14.99
Debt / equity	2.53
Debt / FCF	42.3
Goodwill	$694.4M
Interest coverage	-0.4
Long-term assets	$1.4B
Long-term liabilities	$1.1B
Net cash (debt)	$-854.7M
Net cash / market cap	-174.19%
Net debt / EBITDA	14
Net debt / equity	2.23
Net debt / FCF	37.26
Piotroski F-Score	5
Property, plant and equipment	$4.9M
Shareholders' equity	$383.2M
Tangible book value	$-945.3M
Tangible book value per share	$-8.39
Total assets	$2B
Total cash	$115.7M
Total debt	$970.4M
Total liabilities	$1.6B
WACC	7.06%

Metric

Value

Altman Z-Score

0.36

Book value per share

$3.40

Debt / EBITDA

14.99

Debt / equity

2.53

Debt / FCF

42.3

Goodwill

$694.4M

Interest coverage

-0.4

Long-term assets

$1.4B

Long-term liabilities

$1.1B

Net cash (debt)

$-854.7M

Net cash / market cap

-174.19%

Net debt / EBITDA

Net debt / equity

2.23

Net debt / FCF

37.26

Piotroski F-Score

Property, plant and equipment

$4.9M

Shareholders' equity

$383.2M

Tangible book value

$-945.3M

Tangible book value per share

$-8.39

Total assets

$2B

Total cash

$115.7M

Total debt

$970.4M

Total liabilities

$1.6B

WACC

7.06%

Metric	Value
Asset turnover	0.95
Current assets	$610.5M
Current liabilities	$492.8M
Current ratio	1.24
Net working capital	$3.5M
Quick ratio	1.15
Working capital	$117.7M
Working capital turnover	34.26

Metric

Value

Asset turnover

0.95

Current assets

$610.5M

Current liabilities

$492.8M

Current ratio

1.24

Net working capital

$3.5M

Quick ratio

1.15

Working capital

$117.7M

Working capital turnover

34.26

Metric	Value
Buyback yield / dilution	2.39%
Dividend yield	0%
Shareholder yield	2.39%

Metric

Value

Buyback yield / dilution

2.39%

Dividend yield

Shareholder yield

2.39%

Metric	Value
10Y price change	-79.42%
10Y return CAGR	-14.63%
10Y total return	-79.42%
150-day SMA	$4.12
1D price change	-2.26%
1M price change	18.84%
1M total return	18.84%
1W price change	-11.91%
1W total return	-11.91%
1Y price change	-43.85%
1Y return CAGR	-43.87%
1Y total return	-43.85%
20-day SMA	$4.33
200-day SMA	$3.87
3M price change	12.6%
3M total return	12.6%
3Y price change	-82.11%
3Y return CAGR	-43.65%
3Y total return	-82.11%
50-day SMA	$4.21
50-day SMA vs 200-day SMA	50over200
52-week high	$7.66
52-week high date	2025-10-28
52-week low	$2.10
52-week low date	2026-04-02
5Y price change	-85.08%
5Y return CAGR	-31.65%
5Y total return	-85.08%
6M price change	23.63%
6M total return	23.63%
All-time high	$39.78
All-time high date	2022-09-15
All-time low	$2.10
All-time low date	2026-04-02
Average true range (ATR)	$0.27
Average volume	1.8M
Beta (1Y)	2.36
Beta (2Y)	0.48
Beta (5Y)	1.02
Change from 52-week high	-43.57%
Change from 52-week low	106.21%
Change from all-time high	-89.22%
Change from all-time low	104.77%
Change from open	-3.03%
Day's gap	0.79%
Dollar volume	$5.3M
High price	$4.46
Low price	$4.27
Monthly RSI	39.37
Open price	$4.46
Position in 52-week range	27.03%
Premarket change	-0.45%
Premarket close	$4.42
Premarket price	$4.40
Previous close	$4.42
Price vs 150-day SMA	4.25%
Price vs 20-day SMA	-0.9%
Price vs 200-day SMA	10.97%
Price vs 50-day SMA	1.92%
Relative volume	0.68
RSI	48.84
Sharpe ratio	-0.37
Sharpe ratio (3Y)	-0.5
Sharpe ratio (5Y)	-0.34
Sortino ratio	-0.47
Sortino ratio (3Y)	-0.62
Sortino ratio (5Y)	-0.39
Volume	1.2M
Weekly RSI	50.08
YTD price change	7.25%
YTD total return	7.25%

Metric

Value

10Y price change

-79.42%

10Y return CAGR

-14.63%

10Y total return

-79.42%

150-day SMA

$4.12

1D price change

-2.26%

1M price change

18.84%

1M total return

18.84%

1W price change

-11.91%

1W total return

-11.91%

1Y price change

-43.85%

1Y return CAGR

-43.87%

1Y total return

-43.85%

20-day SMA

$4.33

200-day SMA

$3.87

3M price change

12.6%

3M total return

12.6%

3Y price change

-82.11%

3Y return CAGR

-43.65%

3Y total return

-82.11%

50-day SMA

$4.21

50-day SMA vs 200-day SMA

50over200

52-week high

$7.66

52-week high date

2025-10-28

52-week low

$2.10

52-week low date

2026-04-02

5Y price change

-85.08%

5Y return CAGR

-31.65%

5Y total return

-85.08%

6M price change

23.63%

6M total return

23.63%

All-time high

$39.78

All-time high date

2022-09-15

All-time low

$2.10

All-time low date

2026-04-02

Average true range (ATR)

$0.27

Average volume

1.8M

Beta (1Y)

2.36

Beta (2Y)

0.48

Beta (5Y)

1.02

Change from 52-week high

-43.57%

Change from 52-week low

106.21%

Change from all-time high

-89.22%

Change from all-time low

104.77%

Change from open

-3.03%

Day's gap

0.79%

Dollar volume

$5.3M

High price

$4.46

Low price

$4.27

Monthly RSI

39.37

Open price

$4.46

Position in 52-week range

27.03%

Premarket change

-0.45%

Premarket close

$4.42

Premarket price

$4.40

Previous close

$4.42

Price vs 150-day SMA

4.25%

Price vs 20-day SMA

-0.9%

Price vs 200-day SMA

10.97%

Price vs 50-day SMA

1.92%

Relative volume

0.68

RSI

48.84

Sharpe ratio

-0.37

Sharpe ratio (3Y)

-0.5

Sharpe ratio (5Y)

-0.34

Sortino ratio

-0.47

Sortino ratio (3Y)

-0.62

Sortino ratio (5Y)

-0.39

Volume

1.2M

Weekly RSI

50.08

YTD price change

7.25%

YTD total return

7.25%

Metric	Value
Float	94.2M
Float percentage	83.34%
Shares change (QoQ)	0.57%
Shares change (YoY)	-2.39%
Shares held by insiders	1.95%
Shares held by institutions	82.61%
Shares outstanding	113.1M
Short % of float	13.7%
Short % of shares	11.42%
Short ratio	5.4 days

Metric

Value

Float

94.2M

Float percentage

83.34%

Shares change (QoQ)

0.57%

Shares change (YoY)

-2.39%

Shares held by insiders

1.95%

Shares held by institutions

82.61%

Shares outstanding

113.1M

Short % of float

13.7%

Short % of shares

11.42%

Short ratio

5.4 days

Evolent Health, Inc. (EVH)

Price

Financial snapshot

Fair-value bridge

Latest news · EVH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EVH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EVH

Frequently asked questions